SLS Europe is coordinator of the priMe project, that evaluates the efficacy and safety of a new vaccine candidate against tuberculosis (TB).
TB is one of the top 10 causes of death worldwide. An estimated 10 million people fell ill with TB in 2020 with approximately 1.4 million dying from the disease. In children, BCG vaccination can protect against, or at least ameliorate, severe forms of systemic TB, particularly TB meningitis. Ultimately, to interrupt transmission of the disease, highly contagious pulmonary forms of TB also need to be targeted by vaccination.
For more information visit prime-vaccine.eu